Diabetes

Type 2 diabetes: pharmacological management strategies

Current and future treatment options for the management of patients with type 2 diabetes.…

FDA approval for potassium lowering drug comes with label warning

The US Food and Drug Administration has approved a new drug to treat potentially fatal levels of potassium in patients with chronic kidney disease.…

DPP-4 inhibitors show benefits over sulfonylureas as add-on diabetes therapy

Patients with diabetes who add dipeptidyl peptidase-4 inhibitors to their metformin therapy have a lower risk of stroke and hypoglycaemia, study shows.…

Metformin associated with height increase in children

Decreases in body mass index in children treated with metformin could be partly due to increases in height, according to the results of a new study.…

Diabetic enteropathy discovery raises hopes of treatment

Gastrointestinal problems experienced by type 1 diabetes patients could be treated with an experimental drug that inhibits insulin-like growth factor binding protein 3. …

Reprogrammed pancreatic cells could treat type 1 diabetes

Pancreatic beta cells destroyed in type 1 diabetes could be replaced with other pancreatic cells reprogrammed to produce insulin, suggests study…

High blood pressure linked with onset of diabetes

Data from 4.1 million patients in the UK found that high blood pressure was indepdendently associated with an increased risk of developing diabetes.…

US FDA approves two injectable diabetes treatments

Two drugs that improve blood sugar control in patients with type 1 and type 2 diabetes have been given marketing authority in the United States.…

Diabetes drug empagliflozin cuts cardiovascular deaths by nearly 40%

The diabetes drug empagliflozin could cut the number of cardiovascular deaths by almost 40% as part of the treatment for type 2 diabetes, according to a study published in New England Journal of Medicine.…

Taking blood pressure medication at bedtime reduces risk of developing diabetes

Taking blood pressure therapy first thing in the morning puts patients at a greater risk of developing diabetes than if they take their drugs as they settle down to sleep, researchers in Spain have shown.…